Normalized names for clinical drugs: RxNorm at 6 years
Normalized names for clinical drugs: RxNorm at 6 years
复制标题
DOI：
10.1136/amiajnl-2011-000116
复制
发表时间：
2011-07-01
影响因子：
6.4
通讯作者：
Moore, Robin
中科院分区：
文献类型：
--
作者：
Nelson, Stuart J.;Zeng, Kelly;Moore, Robin
目的自国家医学图书馆开始每月发布RxNorm以来的6年中，RxNorm已成为交流临床药物信息和支持药物词汇表之间互操作的中心资源。材料与方法建立在给定抽象水平的规范化药物名称的思想基础上，RxNorm基于11个不同的外部来源词汇表提供了一组名称和关系。标准模型允许在适当的抽象级别上为各种用途提供决策支持。随着退伍军人管理局国家药品档案参考术语(NDF-RT)的加入，更复杂的决策支持成为可能。讨论尽管RxTerms、RxNav、MyMedicationList和MyRxPad等相关产品已被公认为有助于各种用途，但识别市场上到底有什么和没有什么仍然是一个挑战。
Objective In the 6 years since the National Library of Medicine began monthly releases of RxNorm, RxNorm has become a central resource for communicating about clinical drugs and supporting interoperation between drug vocabularies.Materials and methods Built on the idea of a normalized name for a medication at a given level of abstraction, RxNorm provides a set of names and relationships based on 11 different external source vocabularies. The standard model enables decision support to take place for a variety of uses at the appropriate level of abstraction. With the incorporation of National Drug File Reference Terminology (NDF-RT) from the Veterans Administration, even more sophisticated decision support has become possible.Discussion While related products such as RxTerms, RxNav, MyMedicationList, and MyRxPad have been recognized as helpful for various uses, tasks such as identifying exactly what is and is not on the market remain a challenge.